{"title":"土耳其新冠肺炎患者隔离期间强迫症状及相关因素的在线识别","authors":"S. Havlioğlu, S. Kahraman, Yusuf Kizir, U. Acar","doi":"10.1024/2673-8627/a000023","DOIUrl":null,"url":null,"abstract":"Abstract. Aim: Via online interviews, this study identifies the obsessive-compulsive symptoms (OCSs) of patients diagnosed with Covid-19 and quarantined at home for 14 days, to determine the incidence of these symptoms, to detect OCSs in the early period, and to identify the associated risk factors. Method: This research was designed as a descriptive and cross-sectional study. The study population consisted of patients who had tested positive in the real-time PCR test for Covid-19 and were quarantined at home in the Şanlıurfa Province of Turkey. The study sample comprised 800 patients contacted between January and April 2021. The data were collected online using a questionnaire that included sociodemographic characteristics, questions on postinfection changes, and the Padua Inventory, a valid tool for determining the level of OCSs. Results: The frequency of obsessive-compulsive symptoms during quarantine was calculated as 11.2%, and the mean Padua Inventory score was 48.19 ± 19.17. Conclusion: The results of this study show that patients quarantined at home for 14 days with the diagnosis of Covid-19 are less likely to exhibit obsessive-compulsive symptoms during this period. It also shows that the risk of OCSs was lower particularly in patients who had completed a university or higher education and had no previous psychiatric disease or chronic disease diagnosis.","PeriodicalId":29838,"journal":{"name":"European Journal of Psychology Open","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2022-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Online Identification of Obsessive-Compulsive Symptoms and Relevant Factors in Patients with Covid-19 in Turkey During Quarantine\",\"authors\":\"S. Havlioğlu, S. Kahraman, Yusuf Kizir, U. Acar\",\"doi\":\"10.1024/2673-8627/a000023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract. Aim: Via online interviews, this study identifies the obsessive-compulsive symptoms (OCSs) of patients diagnosed with Covid-19 and quarantined at home for 14 days, to determine the incidence of these symptoms, to detect OCSs in the early period, and to identify the associated risk factors. Method: This research was designed as a descriptive and cross-sectional study. The study population consisted of patients who had tested positive in the real-time PCR test for Covid-19 and were quarantined at home in the Şanlıurfa Province of Turkey. The study sample comprised 800 patients contacted between January and April 2021. The data were collected online using a questionnaire that included sociodemographic characteristics, questions on postinfection changes, and the Padua Inventory, a valid tool for determining the level of OCSs. Results: The frequency of obsessive-compulsive symptoms during quarantine was calculated as 11.2%, and the mean Padua Inventory score was 48.19 ± 19.17. Conclusion: The results of this study show that patients quarantined at home for 14 days with the diagnosis of Covid-19 are less likely to exhibit obsessive-compulsive symptoms during this period. It also shows that the risk of OCSs was lower particularly in patients who had completed a university or higher education and had no previous psychiatric disease or chronic disease diagnosis.\",\"PeriodicalId\":29838,\"journal\":{\"name\":\"European Journal of Psychology Open\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2022-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Psychology Open\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.1024/2673-8627/a000023\",\"RegionNum\":4,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHOLOGY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Psychology Open","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1024/2673-8627/a000023","RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHOLOGY, MULTIDISCIPLINARY","Score":null,"Total":0}
Online Identification of Obsessive-Compulsive Symptoms and Relevant Factors in Patients with Covid-19 in Turkey During Quarantine
Abstract. Aim: Via online interviews, this study identifies the obsessive-compulsive symptoms (OCSs) of patients diagnosed with Covid-19 and quarantined at home for 14 days, to determine the incidence of these symptoms, to detect OCSs in the early period, and to identify the associated risk factors. Method: This research was designed as a descriptive and cross-sectional study. The study population consisted of patients who had tested positive in the real-time PCR test for Covid-19 and were quarantined at home in the Şanlıurfa Province of Turkey. The study sample comprised 800 patients contacted between January and April 2021. The data were collected online using a questionnaire that included sociodemographic characteristics, questions on postinfection changes, and the Padua Inventory, a valid tool for determining the level of OCSs. Results: The frequency of obsessive-compulsive symptoms during quarantine was calculated as 11.2%, and the mean Padua Inventory score was 48.19 ± 19.17. Conclusion: The results of this study show that patients quarantined at home for 14 days with the diagnosis of Covid-19 are less likely to exhibit obsessive-compulsive symptoms during this period. It also shows that the risk of OCSs was lower particularly in patients who had completed a university or higher education and had no previous psychiatric disease or chronic disease diagnosis.